Stay updated on Aducanumab in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.

Latest updates to the Aducanumab in Early Alzheimer's Clinical Trial page
- Check5 days agoChange DetectedThe page now displays an updated revision label (v3.5.4) replacing the previous v3.5.3, indicating a newer page revision without changing substantive study content.SummaryDifference0.0%

- Check12 days agoChange DetectedThe Taiwan site entry was updated from Taoyuan, Taiwan, 333 to Taoyuan County, Taiwan, 333, correcting the locality naming in the study's Contacts and Locations section. This change clarifies the geographic location of the site in the trial's location list.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedUpdates the displayed site revision identifier from **v3.5.2** to **v3.5.3** on the page footer.SummaryDifference0.0%

- Check34 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded Naples, Italy (postal codes 80131 and 80138) to the study locations and removed Napoli, Italy (postal codes 80131 and 80138).SummaryDifference0.0%

- Check63 days agoChange DetectedAdded front-end revision v3.5.0 and removed revision v3.4.3; no changes to study content or user-facing information.SummaryDifference0.0%

Stay in the know with updates to Aducanumab in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.